Company: IRadimed Corporation
Ticker: Nasdaq: IRMD
Sector: Healthcare
Investor Contact: Joe Dorame

IRadimed Corporation News

News

IRADIMED CORPORATION Announces First Quarter 2021 Financial Results

Reports first quarter 2021 revenue of $9.2 million, GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.13Reports combined cash and investments of $52.7 million as of March 31, 2021 WINTER SPRINGS, Fla., April 30, 2021 -- IRADIMED CORPORATION (the "Company")...

IRADIMED CORPORATION Announces Fourth Quarter 2020 Financial Results

Reports fourth quarter 2020 revenue of $8.5 million, GAAP diluted EPS of $0.05 and non-GAAP diluted EPS of $0.07Reports combined cash and investments of $52.0 million as of December 31, 2020 WINTER SPRINGS, Fla., Feb. 04, 2021 -- IRADIMED CORPORATION (the "Company")...

IRADIMED CORPORATION Announces Third Quarter 2020 Financial Results

Reports third quarter 2020 revenue of $7.7 million, GAAP diluted EPS of $0.09 and non-GAAP diluted EPS of $0.11Reports combined cash and investments of $49.9 million as of September 30, 2020 WINTER SPRINGS, Fla., Oct. 30, 2020 -- iRadimed Corporation (the "Company")...

IRADIMED CORPORATION Announces Second Quarter 2020 Financial Results

Reports second quarter 2020 revenue of $6.8 million, GAAP diluted EPS of $(0.17) and non-GAAP diluted EPS of $0.05Reports combined cash and investments of $47.8 million as of June 30, 2020 WINTER SPRINGS, Fla., July 30, 2020 -- iRadimed Corporation (the "Company")...

Skip to content